Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
join remind View in APP

Zoelli Pharmaceutical (300181.SZ)

Questioning stocks
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Zoelli Pharmaceutical (sz300181) rating was released in three research reports, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Zhejiang Zoelli Pharmaceutical Co., Ltd

      Main business:

      The research and development of medicinal fungi Wuling series and Bailing tablet products, Chinese herbal decoction pieces and Chinese herbal formula granules

      Telephone: 0572-8281383

      Fax: 0572-8281246

      Date of establishment: 2000-01-28

      Listing date: 2011-02-22

      Legal representative: Wang Tao

      general manager: Wang Tao

      Registered capital: 70.1387 million yuan

      Issue price: 23.500 yuan

      Latest total share capital: 701387335 shares

      Latest outstanding shares: 60134534 shares

      Segment: GEM Shanghai and Shenzhen A-share Shenzhen A-share Shenzhen Composite Index Manufacturing index Pharmaceutical index Pharmaceuticals Immunotherapy Shenzhen Stock Connect Shenzhen Stock Connect Pharmaceutical Biology Traditional Chinese Medicine II

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share 0.2030 yuan 0.5460 yuan 0.4090 yuan RMB 0.2818 0.1389 yuan
      net asset value per share 4.0819 yuan 3.8905 yuan 3.8030 yuan 3.7118 yuan 3.9302 yuan
      Net operating cash flow per share 0.0243 yuan 0.4113 yuan 0.3193 yuan 0.1756 yuan 0.0171 yuan
      Return on net assets 4.97% 14.03% 10.75% 7.59% 3.54%
      Undistributed profit per share 1.2499 yuan 1.0469 yuan 0.9099 yuan 0.7827 yuan 0.9837 yuan
      Capital reserve per share 1.6187 yuan 1.6187 yuan 1.6187 yuan 1.6187 yuan 1.6187 yuan
      Date of announcement Allocation scheme
      2024-05-15 10 Pairs 4.5 yuan
      2023-05-23 10 pies, 3 yuan
      2022-05-24 10 pairs, 2 yuan
      2021-05-25 10 pairs1 yuan
      2020-05-28 10 pairs 0.2 yuan
      2024-03
      2023-12
      2023-09
      Name of shareholders Shareholding (%) Increase or decrease
      Yu Youqiang five point four zero zero Unchanged
      Wang Kefang three point seven two one Overweight
      Peng Tao two point two three five reduce one's shares in a listed company
      National Social Security Fund IV one point nine six zero Overweight
      China Construction Bank Co., Ltd one point three six four Unchanged
      Dong Hongyu one point one five six reduce one's shares in a listed company
      China Merchants Bank Co., Ltd one point zero two five Overweight
      China Construction Bank Co., Ltd zero point nine five nine New progress
      Deqing County Wuling Equity zero point eight two four New progress
      Tanzhen, Yiwu, Zhejiang zero point six seven five New progress

      Shareholding ratio of circulating shareholders



      user name:
      Password: